Literature DB >> 21229040

Obsessive Compulsive Disorder: Improving prognosis through therapy and drug treatment.

V Goli, R Krishnan, E Ellinwood.   

Abstract

An estimated three to seven million Americans suffer from obsessive compulsive disorder at some time in their lives. Until recently, obsessive compulsive disorder was considered refractory to most treatments. However, recent studies indicate a better prognosis with behavioral therapy, antidepressant medications, or both. Behavioral treatment is generally more effective for compulsions than for obsessions.

Entities:  

Year:  1991        PMID: 21229040      PMCID: PMC2145391     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

1.  Treatment of obsessive compulsive neurosis: pharmacological approach.

Authors:  J Ananth
Journal:  Psychosomatics       Date:  1976       Impact factor: 2.386

2.  The treatment of obsessive-compulsive neurotics by modelling and flooding in vivo.

Authors:  S Rachman; I M Marks; R Hodgson
Journal:  Behav Res Ther       Date:  1973-11

3.  Effects of imaginal exposure to feared disasters in obsessive-compulsive checkers.

Authors:  E B Foa; G Steketee; R M Turner; S C Fischer
Journal:  Behav Res Ther       Date:  1980

4.  Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.

Authors:  J Ananth; J C Pecknold; N van den Steen; F Engelsmann
Journal:  Prog Neuropsychopharmacol       Date:  1981

5.  Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.

Authors:  S A Rasmussen
Journal:  Am J Psychiatry       Date:  1984-10       Impact factor: 18.112

6.  Modified leukotomy in the treatment of intractable obessional neurosis.

Authors:  J Tippin; F A Henn
Journal:  Am J Psychiatry       Date:  1982-12       Impact factor: 18.112

Review 7.  The psychopharmacological treatment of obsessive-compulsive disorder: a review.

Authors:  T R Insel; D L Murphy
Journal:  J Clin Psychopharmacol       Date:  1981-09       Impact factor: 3.153

8.  Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.

Authors:  P Thorén; M Asberg; B Cronholm; L Jörnestedt; L Träskman
Journal:  Arch Gen Psychiatry       Date:  1980-11

9.  Chlorimipramine therapy for obsessive-compulsive neurosis.

Authors:  J Ananth; L Solyom; S Bryntwick; U Krishnappa
Journal:  Am J Psychiatry       Date:  1979-05       Impact factor: 18.112

10.  Lifetime prevalence of specific psychiatric disorders in three sites.

Authors:  L N Robins; J E Helzer; M M Weissman; H Orvaschel; E Gruenberg; J D Burke; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.